Form 4 for IMRX Immuneering Corp
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-15 · accession 0001415889-22-003061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-16 | 2022-03-15 | IMRX | Feinberg Peter | Dir | P - Purchase | $6.75 | +6,667 | 11.8K | +131% | +$45.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-15 | P | A | 6,667 | $6.75 | 11,766 | D | — | — | (F1) This transaction was executed in multiple trades through a broker-dealer at a price of $6.75. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at such price. |